Biophytis

Company Profile

Biophytis had its IPO on 2021-02-10 under the ticker symbol BPTS.

The company operates in the Healthcare sector and Biotechnology industry. Biophytis has a staff strength of 24 employees.

Stock update

Shares of Biophytis opened at $1.44 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.4 - $1.45, and closed at $1.42.

This is a -2.07% slip from the previous day's closing price.

A total volume of 12,427 shares were traded at the close of the day’s session.

In the last one week, shares of Biophytis have increased by 0%.

Biophytis's Key Ratios

Biophytis has a market cap of $7.07 million, indicating a price to book ratio of 1.3528 and a price to sales ratio of 0.

In the last 12-months Biophytis’s revenue was $0 with a gross profit of $0 and an EBITDA of $-23039000. The EBITDA ratio measures Biophytis's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Biophytis’s operating margin was 0% while its return on assets stood at -51.16% with a return of equity of -1244.4%.

In Q1, Biophytis’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Biophytis’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-14.77 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Biophytis’s profitability.

Biophytis stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0.0173. Its price to sales ratio in the trailing 12-months stood at 0.

Biophytis stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0

Total Liabilities

$0

Operating Cash Flow

$0

Capital Expenditure

$308000

Dividend Payout Ratio

0%

Biophytis ended 2024 with $0 in total assets and $0 in total liabilities. Its intangible assets were valued at $0 while shareholder equity stood at $0.

Biophytis ended 2024 with $0 in deferred long-term liabilities, $0 in other current liabilities, in common stock, $0 in retained earnings and $0 in goodwill. Its cash balance stood at $0 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.

Biophytis’s total current assets stands at $0 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $0 and inventory worth $0.

In 2024, Biophytis's operating cash flow was $0 while its capital expenditure stood at $308000.

Comparatively, Biophytis paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.42

52-Week High

$15.4

52-Week Low

$2.26

Analyst Target Price

$150

Biophytis stock is currently trading at $1.42 per share. It touched a 52-week high of $15.4 and a 52-week low of $15.4. Analysts tracking the stock have a 12-month average target price of $150.

Its 50-day moving average was $1.75 and 200-day moving average was $3.44 The short ratio stood at 1.53 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 30.1% are held by institutions.